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ABSTRACT
Microcephaly and medulloblastoma may both result from mutations
that compromise genomic stability. We report that ATR, which is
mutated in the microcephalic disorder Seckel syndrome, sustains
cerebellar growth by maintaining chromosomal integrity during
postnatal neurogenesis. Atr deletion in cerebellar granule neuron
progenitors (CGNPs) induced proliferation-associated DNA
damage, p53 activation, apoptosis and cerebellar hypoplasia in
mice. Co-deletions of either p53 or Bax and Bak prevented
apoptosis in Atr-deleted CGNPs, but failed to fully rescue
cerebellar growth. ATR-deficient CGNPs had impaired cell cycle
checkpoint function and continued to proliferate, accumulating
chromosomal abnormalities. RNA-Seq demonstrated that the
transcriptional response to ATR-deficient proliferation was highly
p53 dependent and markedly attenuated by p53 co-deletion.
Acute ATR inhibition in vivo by nanoparticle-formulated VE-822
reproduced the developmental disruptions seen with Atr deletion.
Genetic deletion of Atr blocked tumorigenesis in medulloblastoma-
prone SmoM2 mice. Our data show that p53-driven apoptosis and
cell cycle arrest – and, in the absence of p53, non-apoptotic cell
death – redundantly limit growth in ATR-deficient progenitors. These
mechanisms may be exploited for treatment of CGNP-derived
medulloblastoma using ATR inhibition.
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INTRODUCTION
Appropriate brain development requires genomic fidelity. Diverse
mutations that increase DNA damage can restrict brain growth,
causing microcephaly (Lee and McKinnon, 2007; McMahon et al.,
2014; Orii et al., 2006; Rosin et al., 2015; Williams et al., 2015).
Combined with p53 deletion, mutations in DNA repair genes may
produce unrestricted growth in medulloblastoma (Frappart et al.,
2009; Lee and McKinnon, 2002; Tong et al., 2003), a malignant
tumor of neural progenitors. The serine/threonine kinase ATR
(ataxia telangiectasia and Rad3-related protein) mitigates
proliferation-associated DNA damage (Brown and Baltimore,
2000) and has been implicated in microcephaly in Seckel
syndrome (O’Driscoll et al., 2003). In mice, conditional deletion
of Atr throughout the CNS during embryonic development
similarly induces microcephaly, but particularly affects the
cerebellum and ganglionic eminence (Lee et al., 2012). The
precise mechanisms that cause DNA damage to impair growth
specifically in the brain are unknown. We investigated the
processes that restrict growth when Atr is deleted in the
cerebellum in order to shed light on the pathogenesis of
microcephaly associated with DNA damage and to determine
whether the reliance of neural progenitors on ATR persists in
progenitor-derived medulloblastoma.
Cerebellar growth depends on the postnatal proliferation of
cerebellar granule neuron progenitors (CGNPs) in the external
granular layer (EGL) along the outside of the cerebellum, which
peaks between postnatal day (P) 5 and 7 (Hatten and Heintz, 1995).
Although Atr deletion in nestin (NES)+ progenitors blocks
cerebellar development prior to postnatal neurogenesis (Lee et al.,
2012), the specific cellular processes restricting the growth of ATR-
deficient progenitors have not been discerned. In vitro, ATR reduces
DNA damage during proliferation by stabilizing stalled replication
forks and by arresting the cell cycle to allow for DNA repair
(Cimprich and Cortez, 2008). Replication fork collapse following
ATR disruption produces DNA double-strand breaks (DSBs),
which are considered the most toxic form of DNA damage (Couch
et al., 2013). ATR also maintains S- and G2-phase checkpoints by
phosphorylating CHK1 (CHEK1) in response to DNA damage
(Smith et al., 2010). Determining how these functions combine in
vivo to sustain neural progenitors is essential to understanding both
the pathogenesis of Seckel syndrome and the requirement for ATR
in brain development.
We found that ATR-deficient CGNPs continued to proliferate
despite accumulating DNA damage, which induced population-
wide, p53-dependent apoptosis. Blocking apoptosis in ATR-
deficient CGNPs through co-deletion of the key apoptotic
mediators Bax and Bak (Bak1) or co-deletion of p53 (Trp53) did
not fully rescue the resulting cerebellar hypoplasia. Rather,
premature cell cycle exit in Atr/Bax/Bak mutants or non-apoptotic
cell death in Atr/p53mutants redundantly limited CGNP population
growth. Atr-deleted CGNPs also demonstrated diverse
chromosomal abnormalities that were intensified by restriction of
apoptosis. CGNPs are the cells of origin for sonic hedgehog (SHH)
subgroup medulloblastomas; we found that Atr deletion blocked the
tumorigenic effect of constitutive SHH activation in transgenic
SmoM2 mice. These investigations define a crucial role for ATR in
maintaining genomic integrity during brain development and
suggest that ATR dependence might be exploited for
medulloblastoma therapy.Received 25 April 2016; Accepted 16 September 2016
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RESULTS
Atr deletion induces CGNP apoptosis and cerebellar
hypoplasia
To analyze ATR function in CGNPs, we generated mice with
conditional Atr deletion (Brown and Baltimore, 2003) in the
MATH1 lineage. Math1 (Atoh1) is expressed by CGNPs in a
rostrocaudal progression beginning at the anterior margins of the
cerebellar cortex at embryonic day (E) 12.5 (Hatten and Roussel,
2011). We crossed the Math1-Cre and AtrloxP/loxP mouse lines to
generate Math1-Cre;AtrloxP/loxP (AtrM-cre) mice.
AtrM-cremice were viable and fertile, but by P12 displayed tremor
and ataxia, suggesting impaired postnatal neurogenesis. These
animals were born with hindbrains of normal appearance, with the
EGL spread over the primordial cerebellum. By P3, however, the
EGL in AtrM-cremicewas noticeably thinner and less foliated than in
Math1-Cre littermate controls with intact Atr (Math1-Cre;Atr+/+ or
Math1-Cre;AtrloxP/+). Cerebellar hypoplasia in AtrM-cre mice
became progressively more apparent with age (Fig. 1A).
We noted sparing of the posterior regions of the cerebellum in
AtrM-cre mice (Fig. 1A, middle row). To determine if this sparing
was the result of incomplete recombination in these regions or was
due to reduced dependence on ATR, we used hGFAP-Cre to delete
Atr throughout the CGNP population. hGFAP-Cremice express Cre
recombinase in neural stem cells, targeting all cells of the
cerebellum except the Purkinje cells (Andrae et al., 2001). In the
resulting hGFAP-Cre;AtrloxP/loxP (AtrG-cre) mice, we found
hypoplasia across the entire EGL. The EGL was thinned by P0
and completely lost by P7. These mice showed more severe tremor
and died by P18 (Fig. 1A, bottom row; Fig. S1A,B).
To understand the cause of cerebellar hypoplasia in Atr mutants,
we analyzed patterns of proliferation, DNA damage and apoptosis
in AtrM-cre and AtrG-cre mice by immunohistochemistry (IHC).
Although prior studies showed that deletion of Atr in Nes-
expressing progenitors blocks the prenatal proliferation of CGNP
precursors (Lee et al., 2012), we observed no reduction in the
postnatal proliferation of CGNPs in P3 AtrM-cre or P0 AtrG-cre
cerebella, as demonstrated by the fraction of EGL cells expressing
the mitosis marker phosphorylated histone H3 (pH3) (Fig. 1B,C,
Fig. S1C) or the cycling cell marker proliferating cell nuclear
antigen (PCNA) (Fig. S3D). However, we found significantly
increased DNA damage as demonstrated by phosphorylated histone
H2A.X (γH2A.X), increased activation of the cellular DNA damage
response as shown by phosphorylated ATM (p-ATM) and p53
(p-p53), and increased apoptosis as shown by the levels of cleaved
caspase 3 (cC3) (Fig. 1B,C, Fig. S1C,D). Atr-deleted CGNPs
therefore proliferate robustly, but accrue extensive DNA damage
and undergo apoptosis.
Deletion of Bax and Bak prevents cell death in Atrmutant
CGNPs
Extensive apoptosis complicated further analysis of ATR-deficient
CGNPs. Prior studies showed that deletion of the apoptosis
gatekeeper Bax is sufficient to stabilize CGNPs with radiation-
induced or proliferation-associated DNA damage (Chong et al.,
2000; Garcia et al., 2013;Williams et al., 2015).We found, however,
that apoptosis of Atr-deleted CGNPs and cerebellar hypoplasia
were not prevented by Bax co-deletion in Math1-Cre;AtrloxP/loxP;
BaxloxP/loxP (Atr;BaxM-cre) animals (Fig. 2A, Fig. S2A,B). Co-
deletion of Atr and the Bax homolog Bak also failed to stabilize the
CGNP population in Math1-Cre;AtrloxP/loxP;Bak−/− (Atr;BakM-cre)
mice (Fig. S2A,B). However, combining genetic deletion of both
Bax and Bak in ATR-deficient mice (Math1-Cre;AtrloxP/loxP;
BaxloxP/loxP;Bak−/−, or Atr;Bax;BakM-cre) effectively prevented
CGNP apoptosis, partially rescuing cerebellar growth (Fig. 2A,B,
Fig. S2A,C). TUNEL staining did not detect non-apoptotic cell
death in Atr;Bax;BakM-cre cerebella that might have been missed by
cC3 studies (Fig. 2B,D). These data show that Atr deletion in
CGNPs, in contrast to other pro-apoptotic stimuli such as radiation,
activated both BAX- and BAK-driven apoptosis.
We comparedmarkers of proliferation,DNAdamage and theDNA
damage response in CGNPs of P3 Atr;BaxM-cre, Atr;Bax;BakM-cre
and Atr-intact Math1-Cre;BaxloxP/loxP;Bak−/− (Bax;BakM-cre)
controls by IHC. The fractions of pH3+ and PCNA+ CGNPs were
similar in Atr mutant and Atr-intact genotypes (Fig. 2D, Fig. S2C,
Fig. S3C,D). CGNPs in Atr;BaxM-cre and Atr;Bax;BakM-cre mice
showed similar levels of γH2A.X. However, p-ATM, p-p53, and the
cell cycle inhibitor p21 (CDKN1A) were all markedly increased in
Atr;Bax;BakM-cre CGNPs (Fig. 2B,D, Fig. S2B,C). Apoptosis-
disabled, ATR-deficient CGNPs were thus able to activate p53
without undergoing cell death.
Atr and p53 double-mutant CGNPs undergo caspase-
independent cell death
To determine the functional significance of p53 activation in
CGNPs of AtrM-cre mice, we examined the phenotype of Math1-
Cre;AtrloxP/loxP;p53loxP/loxP (Atr;p53M-cre) mice. p53 deletion
prevents CGNP apoptosis after radiation-induced DNA damage
(Herzog et al., 1998). p53 deletion did not completely rescue
cerebellar hypoplasia in Atr mutants (Fig. 2A, Fig. S3A), despite
effective suppression of the p53 axis, as demonstrated by the
absence of p21 and p53 activation (Fig. 2C,D). The fraction of pH3+
and PCNA+ CGNPs in Atr;p53M-cre mice did not differ from Atr-
intact controls at P3 (Fig. 2D, Fig. S3B,D). Atr;p53M-cre CGNPs
accumulated significantly more DNA damage than AtrM-cre or Atr;
Bax;BakM-cre CGNPs (Fig. 2D). This increased level of DNA
damage did not trigger activation of caspase 3 (Fig. 2D). However,
TUNEL staining demonstrated that cell death had occurred without
caspase activation (Fig. 2C,D).
Atr;p53M-cre CGNPs showed abnormal morphologies that were
different to the pyknotic nuclei found in the AtrM-cre EGL. These
features included giant multinucleated cells and cells with
micronuclei (Fig. S3E), consistent with published descriptions of
p53-deficient cancer cells undergoing necrosis after DNA damage
(Vakifahmetoglu et al., 2008). To examine whether Atr;p53M-cre
CGNPs were dying through regulated necrosis, we compared the
phosphorylation of MLKL, an essential step in the necroptosis
pathway (Cai et al., 2014). We found scattered CGNPs showing
phosphorylated MLKL (p-MLKL) inMath1-Cre, p53M-cre and Atr;
p53M-cre mice, but no increase in the Atr;p53M-cre genotype
(Fig. S3F). Thus, ATR/p53-deficient CGNPs undergo cell death
without evidence of activating the apoptotic or necroptotic
pathways.
Accelerated cell cycle exit in Atr;Bax;BakM-cre CGNPs
To account for the incomplete rescue of cerebellar growth in Atr;
Bax;BakM-cre and Atr;p53M-cre mice despite the prevention of
CGNP apoptosis, we investigated CGNP proliferation over time.
We compared the mitotic rate of AtrM-cre, Atr;Bax;BakM-cre and Atr;
p53M-cre CGNPs in the EGL with Atr-intact controls at P3, P5 and
P7. We first determined that EGL mitotic rates did not vary
significantly between the Atr-intact Math1-Cre, Bax;BakM-cre and
p53M-cre control genotypes, allowing us to pool controls (Fig. S3G).
The mitotic rates of AtrM-cre CGNPs did not differ from controls
with any statistical significance at P3, P5 or P7: both groups showed
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a small decrease in proliferation by P7 (Fig. 2E). By contrast, the
proliferation rate of Atr;Bax;BakM-cre CGNPs decreased markedly
from P3 to P5 and from P5 to P7, and was significantly lower than in
controls at both P5 and P7. These data show that non-proliferating
cells were increased in the P5 and P7 EGL of Atr;Bax;BakM-cremice
but not in AtrM-cre mice with intact apoptosis. This increased cell
cycle exit at P5 and P7 was p53 dependent, as the mitotic rate of
apoptosis-disabled Atr;p53M-cre CGNPs was significantly higher
than the Atr;Bax;BakM-cre CGNP mitotic rate at both P5 and P7.
We noted clusters of cells in P20 Atr;Bax;BakM-cre cerebella in
the typically depopulated region where the EGL had been. These
cells expressed the neuronal marker NEUN (RBFOX3) (Fig. 2F)
and were PCNA− (data not shown), identifying them as
differentiated neurons. The location of these neurons suggests that
they derive from CGNPs, and similar ectopic neurons were not seen
in AtrM-cre, Atr;p53M-cre or Atr-intact control cerebella. These
observations provide evidence that premature, p53/p21-driven
CGNP cell cycle exit after P3 limits the rescue effect of disabled
apoptosis in Atr;Bax;BakM-cre cerebella.
Cell cycle checkpoint failure in ATR-deficient CGNPs with
DNA damage
ATR coordinates the cellular response to replication stress by
activating cell cycle checkpoints (Abraham, 2001). Our studies of
cerebellar sections indicated that Atr-deleted CGNPs continue to
proliferate after developing detectable DNA damage. To assess
Fig. 1. Atr deletion in CGNPs induces postnatal DNA damage, p53 activation, apoptosis and cerebellar hypoplasia. (A) H&E-stained sagittal brain
sections from mice of the indicated genotypes and ages. (B) Sagittal cerebellar sections from P3 mice of the indicated genotypes stained for pH3, γH2A.X and
cC3. (C) Quantification of replicate cerebella of the indicated genotypes, stained as in B and Fig. S1. Average is shown with s.e.m. P-values by two-sided
independent samples t-test assuming unequal variances. All stainings were repeated on at least three biological replicates (n). Scale bars: 800 µm in A; 400 µm
(main) and 200 µm (inset) for pH3, 50 µm for cC3 (inset) in B.
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checkpoint function in Atr mutants, we used fluorescence-activated
cell sorting (FACS) to analyze freshly isolated CGNPs from
the cerebella of P3 mice with and without Atr deletion, including
AtrM-cre, Atr;Bax;BakM-cre and Atr;p53M-cre knockout genotypes as
well as Math1-Cre, Bax;BakM-cre and p53M-cre controls. All cells
were stained for DNA content (FxCycle Violet), γH2A.X and pH3.
Atr-deleted genotypes showed a strongly γH2A.X+
subpopulation that was not seen in controls (Fig. S4A). To
generate Atr-intact CGNPs with comparable DNA damage, we
subjected P3 wild-type (WT) mice to X-ray radiation (2 Gy) and
then isolated and analyzed CGNPs 2 h later. These WT irradiated
CGNPs showed γH2A.X staining that was comparable in intensity
Fig. 2. Co-deletion of Bax and Bak, but not p53, blocks cell death in ATR-deficient CGNPs. (A) H&E-stained, sagittal brain sections from P12 mice of
the indicated genotypes, showing partial rescue of cerebellar development inAtr;Bax;BakM-cre andAtr;p53M-cremice. (B) Sagittal cerebellar sections fromP3mice
of the indicated genotypes stained for p-p53, TUNEL and p21. (C) Sagittal cerebellar sections from P3 mice of the indicated genotypes stained for γH2A.X,
TUNEL and p21. (D) Quantification of replicate cerebella of the indicated genotypes, stained as in B,C, Fig. S2 and Fig. S3. Bax;BakM-cre and p53M-cre controls
were not significantly different from theMath1-Cre controls presented in Fig. 1. (E) pH3 quantification in the external granular layer (EGL) of mice of the indicated
genotypes at P3, P5 and P7. (F) NEUN staining on P20 sagittal cerebellar sections from mice of the indicated genotypes. Average with s.e.m. P-values by
two-sided independent samples t-test assuming unequal variances. All stainings were repeated on at least three biological replicates (n). Scale bars: 800 µm in A;
400 µm (main) and 50 µm (inset) for p-p53, 200 µm for TUNEL (inset) in B; 400 µm (main) and 200 µm (inset) in C; 200 µm (main) and 50 µm (inset) in F.
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to the γH2A.X+ CGNPs in Atr-deleted mice (Fig. S4A). DNA
content staining effectively identified cells at G1, S and G2/M
phases (Fig. S4A), and pH3 staining distinguished G2 fromMphase
(Fig. S4B). We found no statistically significant differences in cell
cycle distribution between non-irradiated control genotypes
(Fig. S4C), and these controls were pooled for further analysis.
Without γH2A.X selection, comparison of P3 CGNP cell cycle
distribution between controls and Atr-deleted genotypes showed a
significant difference only in the Atr;Bax;BakM-cre CGNPs. These
cells showed enrichment of G2 at the expense of G1 phase
(Fig. 3A), consistent with either delayed progression or G2 arrest.
However, comparing the γH2A.X+ subsets from Atr-deleted
genotypes and irradiated WT mice, we noted marked differences
in M phase. All three Atr-deleted genotypes demonstrated CGNPs
that were both γH2A.X+ and pH3+ (Fig. 3B). By contrast, pH3+
CGNPs were almost undetectable in the irradiated WT mice
(Fig. 3B).
FACS results were confirmed by dual immunofluorescence (IF)
for pH3 and γH2A.X or phospho-53BP1 (p-53BP1; 53BP1 is also
known as TRP53BP1), another marker of DNA damage (Fig. 3C).
First, in WT non-irradiated controls, pH3+ cells were always
negative for γH2A.X and p-53BP1. Second, in irradiated WT mice,
CGNPs that were γH2A.X+ or p-53BP1+ were never pH3+. Finally,
in all Atr-deleted genotypes, γH2A.X+/pH3+ and p-53BP1+/pH3+
cells were common (Fig. 3C). The γH2A.X+/pH3+ CGNPs in Atr-
deleted genotypes either entered M phase with DNA damage or
persisted in M phase after acquiring DNA damage. These data do
not conclusively show whether γH2A.X+, Atr-deleted CGNPs are
able to complete mitosis. However, Atr deletion clearly permitted
cells with DNA damage to be mitotic – a condition that is not seen in
Atr-intact CGNPs.
Additionally, in each of the Atr-deleted genotypes, we found that
γH2A.X+ CGNPs were distributed across all phases of the cell
cycle, with relative enrichment in S, G2 and M phases, compared
with γH2A.X+ CGNPs from irradiated WT mice (Fig. 3D).
Consistent with these data, IF studies showed colocalization of
γH2A.X with markers of G1 (cyclin D1), S (BrdU) and G2 (cyclin
B1) phases (Fig. S4D) in AtrM-cre cerebella. G1 depletion in Atr-
deleted, γH2A.X+ CGNPs could indicate either loss of H2A.X
phosphorylation in G1 cells through DNA repair, or slowed return
of γH2A.X+ cells to G1. The abundance of γH2A.X+ cells in each
phase of the cell cycle, however, suggests that CGNPs with Atr
deletion and DNA damage can progress through the cell cycle and,
in the case of Atr;Bax;BakM-cre, have not all permanently arrested by
P3. Altogether, at this single time point, most ATR-deficient
CGNPs did not show evidence of impaired cell cycle function.
However, Atr deletion increased the fraction of CGNPs with DNA
damage and altered the barriers that normally prevent them from
undergoing mitosis.
FACS data confirmed the increased cell death seen in AtrM-cre and
Atr;p53M-cre CGNPs, which both showed increased sub-G1
fractions. We did not detect an increase in sub-G1 γH2A.X+
CGNPs in Atr;Bax;BakM-cre cerebella (Fig. 3E). These increases in
sub-G1 fractions are consistent with our observations of apoptotic
cell death in the AtrM-cre genotype and non-apoptotic cell death in
the Atr;p53M-cre genotype.
ATR protects CGNP chromosome integrity
Our finding of impaired checkpoint function suggested that
genomic fidelity might be impaired in Atr-deleted CGNPs. In
vitro studies have shown incomplete DNA replication and
chromosomal fragmentation in Atr mutant cells (Brown and
Baltimore, 2000). To determine if chromosomal damage
accumulates in ATR-deficient cells in vivo and to quantify the
damage, we karyotyped Atr-deleted CGNPs freshly harvested from
P3 cerebella. We dissociated CGNPs from AtrM-cre, Atr;Bax;
BakM-cre and Atr;p53M-cre mice and Math1-Cre, Bax;BakM-cre and
p53M-cre controls. Dissociated cells were treated ex vivo with
Colcemid, and metaphase spreads were analyzed by conventional
karyotyping and spectral karyotyping (SKY). We noted frequent
chromosome breaks in all Atr mutant genotypes and a spectrum of
abnormalities, including dicentric chromosomes, end-to-end
fusions, deletions, translocations, and whole chromosome gains or
losses (Fig. 4A). In addition, Atr;p53M-cre CGNP chromosomes
showed segregation defects (premature sister chromatid separation).
These abnormalities were not detected in controls (AtrM-cre 35%,
P<0.01; Atr;Bax;BakM-cre 48%, P<0.01; Atr;p53M-cre 49%, P<0.01;
Student’s t-test).
For statistical analysis, we divided metaphases with varying
degrees of chromosomal damage into four bins: 1-10 chromosome
breaks/cell; >10 chromosome breaks/cell and <50% chromosomes
fragmented (mild); >10 chromosome breaks/cell, >50%
chromosomes fragmented, and some preserved chromosome
morphology (moderate); and >10 chromosome breaks/cell, >50%
chromosomes fragmented, and complete loss of chromosome
morphology (severe) (Fig. 4B). In all Atr-deleted genotypes, the
frequencies of cells with all degrees of chromosomal damage were
increased, but the increases in AtrM-cre cells with moderate and
severe damage were not statistically significant. Moderate and
severe damage, however, were particularly enriched in the
apoptosis-incompetent Atr;Bax;BaxM-cre and Atr;p53M-cre
genotypes (Fig. 4C). These data show that CGNPs require ATR
to maintain chromosomal integrity during proliferation, and that
apoptosis limits the accumulation of genetic abnormalities by
removing damaged cells from the population. Karyotype analyses
also reaffirm that CGNPs with damaged DNA progress to M phase
in Atr mutants.
Transcriptomic adaptations to ATR deficiency are
predominantly p53 driven
We used RNA-Seq to determine the transcriptomic alterations
induced by proliferation-associated DNA damage in the absence of
Atr. Despite a wide body of literature on the cellular consequences
of ATR loss, the impact on the transcriptome had not previously
been reported. The prolonged survival of Atr-deleted CGNPs in Atr;
Bax;BaxM-cre and Atr;p53M-cre mice allowed us to analyze mRNA
abundance without losing cells with DNA damage from the
population through cell death. We isolated and purified total RNA
for RNA-Seq analysis from the cerebella of apoptosis-incompetent,
ATR-deficient P3 mice (Atr;Bax;BakM-cre and Atr;p53M-cre) and
corresponding age-matched controls (Bax;BakM-cre and p53M-cre).
The abundance of mRNAs may be altered by changes in either
production or degradation. ATR has been implicated in RNA
processing (Chandris et al., 2010), and Atr deletion may alter both
gene transcription and mRNA stability. Our data thus identify
transcriptomic, rather than transcriptional changes.
We noted that Atr deletion evoked a richer, more complex pattern
of transcriptomic changes in the Bax/Bak co-deleted background
compared with the p53 co-deleted background. Principal component
analysis (PCA) demonstrated that the second component of variation
explained 16% of variance in global gene expression, and separated
Atr;Bax;BakM-cre from Bax;BakM-cre (P=4.41×10−7, Hotelling’s
t-square test) but not Atr;p53M-cre from p53M-cre (P=0.20,
Hotelling’s t-square test) (Fig. 5A). This difference in separation
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on PCA indicates that p53-deleted CGNPs aremore restricted in their
transcriptomic response to ATR deficiency. Consistent with reduced
transcriptional responsiveness with Atr/p53 co-deletion, the number
of genes differentially expressed in Atr;Bax;BakM-cre cerebella
compared with controls was significantly greater than in Atr;p53M-cre
cerebella compared with controls (P=2.8×10−52, Fisher’s exact test).
Fig. 3. Increased DNA damage and inappropriate mitotic entry in Atr-deleted CGNPs. (A) FACS analysis without subsetting for γH2A.X on CGNPs
from P3mice of the indicated genotypes. M phasewas determined by pH3 labeling. P-values by chi-square test. (B) Quantification of γH2A.X+/pH3+ CGNPs from
P3 mice of the indicated genotypes. P-values by two-sided independent samples t-test assuming unequal variances. (C) Double labeling for γH2A.X/pH3
and p-53BP1/pH3 on sagittal cerebellar sections from P3 mice of the indicated genotypes. Arrowheads indicate double positives. Scale bars: 100 µm (main) and
50 µm (inset). (D) FACS analysis with subsetting for γH2A.X+ CGNPs from P3 mice of the indicated genotypes. P-values by chi-square test. (E) Quantification
of ‘sub-G1’ DNA content detected by FACS in CGNPs from mice of the indicated genotypes. P-values by two-sided independent samples t-test assuming
unequal variances. Average with s.e.m. All stainings were repeated on at least three biological replicates (n).
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Using a false discovery rate (FDR) of <0.01 and considering only
genes meeting a fold-change (FC) criterion of |log2(knockout/
control)|>1.5, we identified 339 genes differentially expressed by
ATR-deficient cells in the Bax/Bak-deleted background, as
compared with 56 genes differentially expressed by ATR-deficient
cells in the p53-deleted background, with nine genes represented in
both sets (Fig. 5B, Tables S1 and S2). This overlap demonstrates a
high degree of correspondence between the gene sets (P=2.0×10−8,
hypergeometric test). However, P-values for differentially
expressed genes were consistently smaller in the p53-deleted
comparison, as visualized in plots of FC versus significance
(Fig. 5C), indicating an overall smaller transcriptomic effect of Atr
deletion in the absence of p53. Expression microarray analysis
comparing mRNA from Atr;Bax;BakM-cre versus Bax;BakM-cre
cerebella defined a gene set that corresponded well with the
differential gene set defined by RNA-Seq (Fig. S5A). By contrast,
microarray analysis was unable to identify any differentially
expressed genes in the Atr;p53M-cre versus p53M-cre comparison,
consistent with an overall low signal-to-noise ratio in the absence
of p53.
Fig. 4. Atr deletion compromises the chromosome integrity of proliferating CGNPs. (A) Metaphase chromosome spread and SKY analysis on Atr;Bax;
BakM-cre and Atr;p53M-cre CGNPs. (B) Severity of chromosome damage in CGNPs with >10 chromosome breaks/cell, grouped into mild, moderate and severe.
(C) The distribution of CGNPs with chromosomal abnormalities by genotype. Average with s.e.m. P-values by two-sided independent samples t-test assuming
unequal variances. n, number of biological replicates, with 35-50 metaphases counted per replicate.
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Pathway analysis of the 339 genes differentially expressed in Atr;
Bax;BaxM-cre CGNPs demonstrated a strong correspondence
between these genes and the molecular signature of p53-
dependent transcription. Activation of p53 can induce both
apoptosis and cell cycle arrest (Zuckerman et al., 2009), and we
noted that regulators of both processes were enriched in the Atr;Bax;
BaxM-cre gene set (Table 1). By contrast, we did not identify any
pattern in Atr;p53M-cre CGNPs that could be attributed to a specific
transcriptional regulator (Table S3) and, consistent with the lack of
increased MLKL activation, we found no elevation of necroptosis-
associated genes such as RIP kinases.
We used IF to determine the protein expression patterns of
trophinin (TRO), which was among the nine genes identified as
differentially expressed in bothAtr-deleted genotypes, and for which
wewere able to obtain effective antibodies. Examining Bax;BakM-cre
and p53M-cre control brains, we found that TRO was expressed in all
differentiated neurons of the brain, but absent in progenitor regions
(Fig. 5D). In Atr-deleted Atr;Bax;BaxM-cre and Atr;p53M-cre
Fig. 5. The p53 pathway controls the CGNP transcriptomic response to Atr deletion. (A) PCA on gene expression of CGNPs from P3 mice of the indicated
genotypes, as determined by RNA-Seq. (B) Differential gene expression analysis of RNA-Seq data using the indicated criteria comparing mice of the
indicated genotypes. (C) Volcano plots of log2(FC) versus −log10(P-value) for Atr;Bax;BakM-cre compared with Bax;BakM-cre and for Atr;p53M-cre compared
with p53M-cre, with color threshold (teal dots) set at log2(FC)>1.5 and FDR<0.01 (lines). (D) IF for TRO and EIF4EBP1 on sagittal cerebellar sections from P3mice
of the indicated genotypes. Arrows indicate TRO+ cells. Scale bar: 100 µm. IGL, internal granular layer. All stains were repeated on at least three biological
replicates (n).
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cerebella, however, TRO was detected within the CGNP layer
(EGL), indicating upregulation of the protein as well as the RNA.
From the larger set of 124 genes that were upregulated in the Atr
mutant cerebella of both p53-deleted and Bax/Bak-deleted
backgrounds with FDR<0.01, irrespective of FC, we selected
Eif4ebp1 for further analysis. EIF4EBP1 is known to regulate
protein translation downstream of mTOR (Fingar et al., 2002), a
PIKK kinase homologous to ATR (Lovejoy and Cortez, 2009). Atr-
deleted CGNPs demonstrated marked upregulation of EIF4EBP1
protein. In control cerebella, EIF4EBP1 was limited to a subset of
CGNPs at the outer margin of the EGL, whereas in Atr-deleted
cerebella EIF4EBP1 was detected throughout the EGL (Fig. 5D).
Our in situ IF data, along with our microarray results, thereby
validate our RNA-Seq findings.
We further examined our RNA-Seq data to determine whether Atr
deletion produced recurrent point mutations or other changes in
RNA sequence. We did not detect a significant change in mismatch
rate associated with Atr deletion (Fig. S5B). Fusion transcript
detection software suggested a small number of fusion products,
only one of which, with unknown biological function, emerged with
statistical significance (Fig. S5C). Together with our karyotype
analysis, these data suggest that, although Atr deletion significantly
altered chromosome structure, it did not substantially increase the
rate of point mutations or recurrent fusion transcripts.
ATR is required for medulloblastoma tumorigenesis
Prior studies have shown that deletion of diverse DNA repair
pathway genes, combined with p53 deletion, induces
medulloblastoma in mice (Frappart et al., 2007, 2009; Holcomb
et al., 2006; Lee and McKinnon, 2002). To determine if Atr
mutation predisposes mice to medulloblastoma, we followed the
viability and neurologic function of 12 Atr;p53M-cre and 12 Atr;Bax;
BakM-cremice for more than 300 days (supplementaryMaterials and
Methods). These mice showed no progressive neurological changes
or other evidence of tumorigenesis, and their cerebella remained
hypoplastic (data not shown). The absence of tumors despite
impaired genomic stability and p53 deletion suggests that
medulloblastoma tumorigenesis, like postnatal neurogenesis,
might require ATR function.
We directly tested this suggested requirement for ATR in
medulloblastoma tumorigenesis by deleting Atr in tumor-prone
hGFAP-Cre;SmoM2 mice (Schuller et al., 2008). CGNPs in
SmoM2G-cre mice with intact Atr gave rise to medulloblastoma
with 100% frequency by P7, causing the mice to die from tumor
progression by P20 (Fig. 6A). By contrast, Atr deletion in SmoM2;
AtrG-cre animals completely blocked tumor formation, as seen and
quantified by Hematoxylin and Eosin (H&E) staining and by IF for
PCNA, which marks proliferating tumor cells (Fig. 6A). The
inability of Atr-deleted CGNPs in SmoM2;AtrG-cre mice to give rise
to tumors suggests that ATR inhibition might effectively restrict
medulloblastoma growth.
ATR inhibitor administered in vivo induces DNA damage
specifically in CGNPs
To determine whether acute disruption of ATR function during
postnatal neurogenesis in WT mice would recapitulate conditional
Atr deletion, we developed a novel formulation of the small
molecule ATR inhibitor VE-822 (pVE-822) (Charrier et al., 2011;
Fokas et al., 2012). We first demonstrated that VE-822 induces
DNA damage and apoptosis in isolated CGNPs in vitro in a time-
and dose-dependent manner (Fig. S6A). To enhance delivery of
VE-822 across the blood-brain barrier, we encapsulated VE-822
in poly(2-oxazoline) micelles, generating pVE-822 (Fig. S6B,C).
We found that pVE-822, administered by intraperitoneal (IP)
injection, induced γH2A.X and cC3 in the EGL, without affecting
the surrounding differentiated neurons in the cerebellum or
cortical neurons (Fig. 6B,C). As with Atr deletion, acute ATR
inhibition by pVE-822 promoted upregulation of EIF4EBP1 in
CGNPs, demonstrating that EIF4EBP1 is an effective biomarker
of ATR disruption (Fig. 6D). These results show that pVE-822
effectively crosses the blood-brain barrier in bioactive
concentrations after IP administration, and that acute, global loss
of ATR function specifically disrupts CGNPs. The absence of
neuronal toxicity associated with pVE-822 administration is
Table 1. Pathway enrichment analysis on significantly differentially expressed genes between CGNPs from P3 Atr;Bax;BakM-cre and Bax;BakM-cre
cerebella
Database Pathway
Fold
enriched FDR Genes
Kyoto Encyclopedia of Genes and
Genomes*
p53 signaling pathway§ 27 5.9E−8 ↑Cdkn1a, ↑Fas, ↑Mdm2, ↑Pmaip1, ↑Sesn2,
↑Trp73, ↓Cdk1, ↓Mdm4
Cell cycle 9 2.0E−3 ↑Cdkn1a, ↑Mdm2, ↓Anapc1, ↓Cdk1, ↓Mcm7
Pathways in cancer 7 1.4E−3 ↑Cdkn1a, ↑Fas, ↑Fgfr3, ↑Itga6, ↑Mdm2, ↑Sos2,
↓Apc
MAPK signaling pathway 9 1.1E−5 ↑Cacnb4, ↑Fas, ↑Fgfr3, ↑Mapkapk3, ↑Pla2g2f,
↑Sos2, ↓Hspa8
Wiki Pathways* Apoptosis 13 6.0E−4 ↑Fas, ↑Mdm2, ↑Pmaip1, ↑Tnfrsf10b, ↑Trp73
miRNA regulation of DNA damage
response
24 6.0E−7 ↑Cdkn1a, ↑Fas, ↑Mdm2, ↑Pmaip1, ↑Tnfrsf10b,
↓Cdk1, ↓Mcm7
G1 to S cell cycle control 14 1.4E−3 ↑Cdkn1a, ↑Mdm2, ↓Cdk1, ↓Mcm7
Gene Ontology Biological Process‡ p53 signal transduction 15 1.7E−4 ↑Cdkn1a, ↑Mdm2, ↑Pmaip1, ↑Sesn2, ↑Trp53inp1,
↓Mdm4
Cell cycle 4 4.4E−4 ↑Cdkn1a, ↑Mdm2, ↑Trp53inp1, ↓Anapc1, ↓Cdk1,
↓Mcm7
Nervous system development 3 3.8E−5 ↑Apoe, ↑Fas, ↑Fgfr3, ↑Gfap, ↑Myh10, ↓Apc, ↓Otx1,
↓Smarcc1
Differentially expressed genes are defined as log2(FC)>1.5 and FDR<0.01. Subset by consensus between RNA-Seq andmicroarray. Arrows indicate whether an
individual gene within that pathway is upregulated or downregulated.
*Accessed via WebGestalt.
‡Accessed via Panther.
§Also as determined by KEGG accessed via EnrichNet.
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consistent with recent literature demonstrating that ATR inhibition
does not damage non-proliferating, differentiated neurons (Kemp
and Sancar, 2016).
DISCUSSION
Our data show that ATR is required to mitigate endogenous DNA
damage during postnatal CGNP proliferation in order to maintain
genomic stability. A prior study that deleted Atr using Nes-Cre,
which is expressed by E9.5 with an effect by E10.5, found that
embryonic CGNP precursors exit the cell cycle prematurely,
blocking cerebellar development before postnatal CGNP
proliferation (Lee et al., 2012). By contrast, in AtrG-cre and AtrM-
cremice, whereCre expression does not occur until E11.5 and E12.5
(Andrae et al., 2001; Machold and Fishell, 2005), respectively,
CGNPs proliferated normally in the postnatal period and the effect
of Atr deletion was not observed until P0 and P3, respectively.
Fig. 6. Atr deletion blocks medulloblastoma tumorigenesis, and acute in vivo ATR inhibition induces DNA damage and apoptosis in the postnatal
cerebellum. (A) Sagittal H&E- and PCNA-stained brain sections at P7 and P20 show the absence of tumor formation in SmoM2;AtrG-cre mice. Bar charts
compare total area and percentage PCNA+ cells in the P20 posterior fossa by genotype. (B-D) Sagittal sections of whole brains, cerebella and cortices from
P5WT mice injected with pVE-822 or vehicle, stained for (B) γH2A.X, (C) cC3 or (D) EIF4EBP1. Arrows indicate EIF4EBP1+ cells. Average with s.e.m. P-values
by two-sided independent samples t-test assuming unequal variances. All stainings were repeated on at least three biological replicates (n). Scale bars: 2 mm
in A; 2 mm (brain), 500 µm (cerebellum) and 100 µm (EGL and cortex) in B-D.
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Postnatal proliferation in Atr-deleted CGNPs produced widespread
DNA damage that activated ATM and p53 and induced apoptosis,
resulting in cerebellar hypoplasia.
Blocking apoptosis by co-deletion of Bax and Bak or p53 did not
fully rescue cerebellar hypoplasia. Cerebellar growth failure
persisted despite attenuation of apoptosis due to inappropriate cell
cycle exit and differentiation in Atr;Bax;BakM-cre CGNPs or
caspase-independent cell death in Atr;p53M-cre CGNPs.
Karyotype analysis showed that Atr-deleted CGNPs developed
extensive chromosomal abnormalities, and RNA-Seq analysis
revealed the p53 pathway to be the predominant driver of the
transcriptomic response to ATR-deficient proliferation.
Atr deletion in medulloblastoma-prone mice (SmoM2;AtrG-cre)
completely abrogated tumor formation, suggesting a therapeutic
potential for ATR inhibition as a novel treatment for
medulloblastoma. The anti-tumor effect of targeting ATR might be
magnified in our model, as early deletion of Atr by hGFAP-Cre
depletes the pool of CGNPs from which tumors may originate.
However, CGNPs were present in P0 AtrG-cre mice (Fig. 1A), and
SmoM2 expression consistently failed to induce tumor growth from
these cells in SmoM2;AtrG-cre animals. Future work will assess the
therapeutic potential of the ATR inhibitor pVE-822 in mice with
established medulloblastoma. Indeed, we have already shown here
that acute in vivoATR inhibition by pVE-822 inWTmice reproduces
the effects of conditional Atr deletion. Taken together, these results
define a crucial role for ATR in maintaining genomic integrity in
rapidly proliferating neural progenitors and in medulloblastoma cells.
The finding that 5-9% of Atr-deleted CGNPs were cC3+
demonstrates a strong induction of apoptosis. Unlike CGNP death
after radiation, the death of these cells is not expected to be a
synchronous process. Moreover, dying cells are cC3+ for only a
limited time because they are rapidly cleared by phagocytosis and
cC3 is known to have a short half-life (Elliott and Ravichandran,
2010; Walsh et al., 2011). Detecting 5-9% of cells expressing cC3
thus indicates a high rate of cell death.
Apoptosis in Atr-deleted CGNPs, in contrast to irradiated Atr-
intact CGNPs (Chong et al., 2000; Williams et al., 2015), was not
prevented by co-deletion of Bax, but was prevented by co-deletion
of both Bax and Bak. In other cell types, BAK-driven apoptosis can
be activated by genotoxic stress during mitosis (Chu et al., 2012;
Flores et al., 2012). Atr-deleted CGNPs with DNA damage were
markedly more prone to be mitotic than irradiated CGNPs in Atr-
intact mice. The mitosis of Atr-deleted CGNPs with DNA damage
might activate BAK-driven apoptosis that is not activated by
radiation in WT mice.
The dependence of CGNPs on ATR to prevent DNA damage
suggests that these cells are particularly prone to endogenous
replication stress. ATR is activated in response to stalled DNA
replication forks (Nam and Cortez, 2011), which can be caused by
exogenous (Harley et al., 2016; Harper et al., 2010) or endogenous
(Willis et al., 2013) factors. We have previously shown that normal
CGNP proliferation produces endogenous DNA damage, detectable
as small γH2A.X+ foci (Williams et al., 2015). We now show that
ATR mitigates endogenous, proliferation-associated DNA damage
in CGNPs in order to maintain replication fidelity.
To account for the phenotype of Atr deletion we propose a model
in which: (1) rapid proliferation promotes replication fork stalling
from endogenous sources (Mirkin andMirkin, 2007); (2) absence of
ATR prolongs and collapses forks with consequent formation of
DSBs (Couch et al., 2013); (3) ATM is activated and recruited to
sites of DSBs (Shiloh, 2003); and (4) p-ATM activates p53, which
ultimately induces apoptosis (Shiloh and Ziv, 2013) through BAX
and BAK, and cell cycle arrest through p21 (Fig. 7). Because DNA
damage and apoptosis occur throughout the entire CGNP
population, cerebellar growth is effectively halted.
Apoptosis functions to cull CGNPs that acquire chromosomal
abnormalities; thus, disabling apoptosis in ATR-deficient mice
increases chromosomal fragmentation. p21 upregulation in Atr;Bax;
BakM-cre CGNPs demonstrates that p53-induced cell cycle exit acts
as an additional barrier to the propagation of genomic abnormalities
in apoptosis-incompetent, Atr-deleted CGNPs. Genomic stability in
CGNPs may be particularly important for preventing their rapid
postnatal proliferation from degenerating into tumorigenesis.
Medulloblastoma, the most common malignant pediatric brain
tumor, arises from hindbrain neural progenitors including CGNPs
(Yang et al., 2008). Chromosome damage has been observed in
medulloblastoma, frequently in association with p53 mutation
(Rausch et al., 2012). Importantly, despite severe chromosomal
abnormalities in Atr;Bax;BakM-cre and Atr;p53M-cre mice, we never
observed tumor formation. Indeed, we found that medulloblastoma
tumorigenesis, like cerebellar development, requires ATR.
Since the physiological requirement for ATR in neural
progenitors is recapitulated in the pathological growth of
medulloblastoma, ATR may be a promising target for novel anti-
tumor therapy. pVE-822 effectively crosses the blood-brain barrier
in bioactive concentrations and induces DNA damage in
proliferating cells. By damaging DNA in proliferating cells, pVE-
822 might have a similar toxicity to conventional chemotherapeutic
agents such as etoposide. An advantage of ATR inhibition over
standard chemotherapy, however, is suggested by our data showing
that Atr deletion kills cells even in the absence of p53. Whether the
activity of pVE-822 against proliferating, non-tumor cells will limit
its therapeutic potential remains to be tested.
MATERIALS AND METHODS
Mice
We generated AtrM-cre and AtrG-cre mice by crossing AtrloxP/loxP (Brown and
Baltimore, 2003) mice with the Math1-Cre (Jackson Labs, stock #011104)
(Matei et al., 2005) and hGFAP-Cre (Jackson Labs, stock #012886) (Zhuo
et al., 2001) mouse lines, respectively. BaxloxP/loxP;Bak−/− mice (Takeuchi
et al., 2005) were obtained from Jackson Labs (stock #006329). To generate
mice with co-deletion of Atr/Bax/Bak, Atr/Bax, Atr/Bak and Bax/Bak, we
crossed AtrM-cre and BaxloxP/loxP;Bak−/− animals, intercrossed the progeny,
and selected mice of Atr;Bax;BakM-cre, Atr;BaxM-cre, Atr;BakM-cre and Bax;
BakM-cre genotypes. We generated Atr;p53M-cre mice by crossing AtrM-cre
with p53loxP/loxP mice (Jonkers et al., 2001) provided by the NCI
(strain #01XC2). Medulloblastoma-prone animals with and without Atr
deletion were born from the cross between hGFAP-Cre;AtrloxP/+ and
SmoM2loxP/loxP;AtrloxP/loxP, in which tumorigenesis is induced by deletion
of a loxP-flanked Stop cassette between the Smo promoter and coding
region (Schuller et al., 2008). All mice were of species Mus musculus and
crossed into the C57BL/6 background through at least five generations. We
used equal numbers of male and female mice, as we did not observe any
differences based on sex. Numbers (n) in figures indicate biological
replicates, which were determined so as to measure a 25% difference in
means with power=80% and α=0.05. Animal use was in keeping with the
policies of the University of North Carolina at Chapel Hill Institutional
Animal Use and Care Committee. P3 mice of the indicated genotypes
received 2 Gy whole-body X-ray irradiation and were sacrificed 2 h later.
Immunostaining of cerebellar sections
Mouse brains were processed and immunostained as previously described
(Gershon et al., 2013). Primary antibodies are listed in the supplementary
Materials and Methods. Secondary antibodies of the indicated fluorophores
were used at 1:2000 for IF. Cell death was detected by TUNEL assay
[ThermoFisher Scientific (TFS) #C10617] (Galluzzi et al., 2009). DAPI and
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Hematoxylin were used as nuclear counterstains. BrdU analysis is described
in the supplementary Materials and Methods.
Quantification of immunostaining
Stained slides were digitally imaged and positively stained cells were
counted using Aperio Software (Aperio Technologies) for chromogen-
stained slides or Tissue Studio (Definiens) for fluorescence, as previously
described (Williams et al., 2015). The entire EGL region in each section
was manually annotated and used for quantifications, which were
normalized to the total number of nucleated cells in the designated
region. The measurement of cerebellar cellularity is described in the
supplementary Materials and Methods.
CGNP isolation
CGNPs from P3 Atr-deleted mice and controls were isolated as previously
described (Lee et al., 2009). Briefly, we separated cerebella from the rest of
the brain, removed the meninges, and dissociated the tissue in 20 units/ml
papain (Worthington Biochemical Corporation #PDS) at 37°C for 15 min.
CGNPs were then purified from the dissociated cerebellar tissue by
successive rounds of centrifugation, discontinuous density gradient, and
mesh filtering.
Flow cytometry
Flow cytometry on ATR-deficient CGNPs was performed by first fixing
and permeabilizing (TFS #GAS-004) isolated CGNPs suspended in
HBSS containing 33 mM glucose, as previously described (Stahl et al.,
2008). CGNPs were then stained successively for DNA damage with
e660-conjugated anti-γH2A.X Ser139 (eBioscience #50-9865) at 1:10,
for M phase with 488-conjugated anti-pH3 (Cell Signaling Technology
#9708) at 1:25, and for DNA content with FxCycle Violet (TFS #F-
10347) at 1:50. Technical controls included no stain, single-stained and
fluorescence-minus-one samples. FACS was performed on an LSR
Fortessa (BD Biosciences). For all experiments, 10,000-50,000 cells were
counted. Analysis of FACS data was performed using FlowJo v10.0.8
(FlowJo).
Cytogenetic analysis
Cytogenetic analysis was performed on Atr-deleted CGNP metaphase
spreads. Freshly isolated CGNPs from P3 animals were treated for 30 min
with 100 nM Colcemid (TFS #15210-040) in Neurobasal-A Medium (TFS
#10888-022) supplemented with 1× GlutaMAX-I (TFS #35050), 1×
penicillin-streptomycin and 25 mM KCl at 37°C to block cell cycle
progression in M phase. CGNPs were then were resuspended in 75 mM
KCl, incubated at 37°C for 5 min, and fixed in methanol:acetic acid (3:1).
The fixed cell suspension was dropped onto slides, stained in 0.08 µg/ml
DAPI in 2× SSC for 3 min, and mounted in antifade solution (Vector
Laboratories #H-1200). The stained slides were scanned using a Zeiss
Axioplan 2i epifluorescence microscope equipped with a megapixel CCD
camera (CV-M4+CL, JAI) controlled by Isis 5.2 imaging software
(Metasystems International). Chromatid breaks were counted as single-
break events, tri-radials and quadri-radials as two-break events each, and
other complex chromatid exchanges were converted into the minimum
number of breaks required for their theoretical reconstruction.
Chromosome aberrations (fragments, rings, dicentric/tricentrics and large
marker chromosomes) were recorded and the breaks required for these
rearrangements were not added to the frequency of chromatid breaks.
Fig. 7. ATR is required to maintain G2/M
checkpoint integrity and prevent apoptosis
induced by proliferation-associated DNA
damage. (A) CGNPs proliferate in the postnatal
cerebellum, generating DNA damage (lightning
bolt) from endogenous processes, which stalls
replication forks. ATR is recruited by replication
protein A (RPA), which binds single-stranded DNA
at stalled replication forks. Activated ATR initiates
checkpoint arrest, promoting DNA repair with
minimal engagement of the p53 pathway. (B) ATR
loss prolongs replication fork stalling across the
CGNP genome, which degenerates into
widespread DSBs that are sensed by ATM.
Resultant p53 activation triggers apoptosis through
BAX/BAK and caspase 3 (C-3) due to
overwhelming DNA damage, with some concurrent
activation of p21 and cell cycle arrest. G2/M
checkpoint failure from ATR absence allows
CGNPs with DNA damage to enter mitosis,
incurring chromosomal abnormalities; however,
apoptosis removes cells with aberrant
chromosomes. (C) Co-deletion of Bax and Bak in
ATR-deficient CGNPs prevents apoptosis. Instead,
cells with DNA damage and p53 activation are
driven to p21-mediated cell cycle exit, attenuating
CGNP proliferation over time. However, cells that
escape arrest then inappropriately enter mitosis and
experience chromosome damage, which
accumulates due to apoptotic failure. (D) In Atr;
p53M-cre CGNPs, DSBs from collapsed replication
forks accumulate and propagate due to the inability
to undergo both ATR-mediated G2/M arrest and
p53-mediated apoptosis and cell cycle arrest.
Excessive DNA damage triggers an as yet
unidentified form of non-apoptotic cell death.
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Mutation analysis
The frequency of mismatches or of transcript fusions associated with Atr
deletion were determined as described in the supplementary Materials and
Methods.
Western blot
P3WTCGNPs subject to VE-822 or vehicle were analyzed for γH2A.X and
cC3 (with β-actin loading control) by western blot as described in the
supplementary Materials and Methods.
Spectral karyotyping
Metaphase spreads from the fixed cell suspensions were hybridized with
SKY painting probes according to the manufacturer’s protocol (Applied
Spectral Imaging). SKY images were acquired with an SD300 Spectracube
(Applied Spectral Imaging) mounted on a Nikon Eclipse E800 microscope
using a custom-designed optical filter (SKY-1) (Chroma Technology). For
each sample, a minimum of 20, but usually 50, metaphases were captured
and fully karyotyped. The breakpoints on the SKY-painted chromosomes
were determined by comparison with the corresponding DAPI karyotype
and chromosomal abnormalities were described according to ISCN (2013).
RNA-Seq and differential expression analysis
For RNA-Seq analysis, total RNAwas purified using the RNeasy Mini Kit
(Qiagen #74104) from freshly dissected whole P3 cerebella. RNA quality
and quantity were assessed by spectrophotometry and capillary gel
electrophoresis. We generated stranded mRNA libraries using an Illumina
TruSeq Stranded mRNA Library Prep Kit (Illumina #RS-122-2101).
60 ng/µl poly(A)-selected RNA from each sample was run in two lanes of a
HiSeq 2000 sequencing instrument (Illumina) for 100 cycles of multiplexed
paired-end reads.
We performed read pseudo-alignment and quantification using Kallisto
v0.42.4 [Bray et al. (2015) preprint] with 200 bootstraps/paired-end read,
aligning against the mouse mm9 genomic assembly, GRCm38
transcriptome definition. Downstream analysis was performed using the
edgeR v3.12.0 software package (Robinson et al., 2010) in R-Studio
v0.99.491 with R v2.11.1 (R Core Team, 2014). To assess differential
expression, we used a general linear model in edgeR comparing Atr-deleted
with control, setting the minimum counts per million at 2 and requiring
greater than half the samples to pass the count threshold for a given
transcript. Microarray validation is detailed in the supplementary Materials
and Methods.
Pathway analysis
Biological pathway enrichment was determined by comparing
transcriptomic data with Kyoto Encyclopedia of Genes and Genomes
v77.1 (Kanehisa and Goto, 2000), WikiPathways (Kutmon et al., 2016) and
Gene Ontology v1.2 (Ashburner et al., 2000) databases using EnrichNet
v1.1 (Glaab et al., 2012), Panther v10.0 (Mi et al., 2013), and WebGestalt
(Wang et al., 2013). Only genes above the differential expression
significance threshold of log2(FC)>1.5 and FDR<0.01 were used in
pathway analysis.
pVE-822 in vivo administration
For in vivo studies, WT mice were subject to IP injection with 60 mg/kg
pVE-822 (see supplementary Materials and Methods for formulation) or an
equal volume of vehicle every 12 h for three total injections from P3-5. 12 h
following the final injection, animals were sacrificed and brains were
prepared for immunostaining.
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